Risk-adapted high-dose therapy including autologous and allogeneic stem cell transplantation for relapsed or aggressive non-Hodgkin's lymphoma - a phase II trial by the OSHO (East German Study Group for Haematology and Oncology)
BONE MARROW TRANSPLANTATION（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要